Biotech News
Related news
EMBCEmbecta2026-07-23 21:00 EST
embecta to Report Fiscal Third Quarter Financial Results
EMBCEmbecta2026-11-10 21:40 EST
embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
SGMTSagimet Biosciences2026-11-12 12:30 EST
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
ALGSAligos Therapeutics2026-11-06 13:00 EST
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
CVRXCVRx2026-11-05 21:05 EST
CVRx Reports Third Quarter 2026 Financial and Operating Results
ALTAltimmune2026-11-05 13:00 EST
Altimmune to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
MISTMilestone Pharmaceuticals Inc.2026-11-03 13:00 EST
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
MNKDMannKind2026-10-29 20:01 EST
MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
LXRXLexicon Pharmaceuticals2026-10-29 12:30 EST
Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
MLYSMineralys Therapeutics2026-10-28 20:05 EST
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
Embecta
Global Diabetes Care Embecta is a global diabetes-care company built on a nearly century-long history in insulin delivery. Its products are used by people who self-administer injectable therapies and by healthcare systems supporting diabetes management. Injection-Device Portfolio The company's core portfolio includes pen needles and...
Recent company news
EMBCEmbecta2026-11-10 21:40 EST
embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
EMBCEmbecta2026-08-31 21:00 EST
embecta to Participate in Investor Events
EMBCEmbecta2026-08-07 10:30 EST
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
EMBCEmbecta2026-08-07 10:00 EST
embecta Announces Quarterly Cash Dividend
EMBCEmbecta2026-07-23 21:00 EST
embecta to Report Fiscal Third Quarter Financial Results
Stock data
- Close
- 6.19 USD
- Market cap
- 207.05M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
